- Home
- VLY vs IKT Comparison
VLY vs IKT Comparison
Compare VLY & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VLY | IKT |
|---|---|---|
| Founded | 1927 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 201.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | VLY | IKT |
|---|---|---|
| Price | $11.70 | $2.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $13.10 | $6.00 |
| AVG Volume (30 Days) | ★ 5.8M | 606.6K |
| Earning Date | 01-22-2026 | 11-14-2025 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | ★ 40.78 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $1,704,193,000.00 | N/A |
| Revenue This Year | $33.72 | N/A |
| Revenue Next Year | $10.15 | N/A |
| P/E Ratio | $13.28 | ★ N/A |
| Revenue Growth | ★ 8.06 | N/A |
| 52 Week Low | $7.48 | $1.33 |
| 52 Week High | $12.18 | $3.49 |
Technical Indicators
Market Signals| Indicator | VLY | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 70.97 |
| Support Level | $11.85 | $1.56 |
| Resistance Level | $12.01 | $2.15 |
| Average True Range (ATR) | 0.19 | 0.17 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 6.80 | 82.85 |
Price Performance
Historical ComparisonAbout VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.